​
​

Bausch + Lomb (BLCO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Bausch + Lomb Revenue Highlights

Latest Revenue (Y)

$4.15B

Latest Revenue (Q)

$1.20B

Main Segment (Y)

Device Products

Main Geography (Y)

United States and Puerto Rico

Bausch + Lomb Revenue by Period

Bausch + Lomb Revenue by Year

DateRevenueChange
2023-12-31-10.03%
2022-12-31-0.08%
2021-12-31-10.35%
2020-12-31--9.69%
2019-12-31-3.08%
2018-12-31--

Bausch + Lomb generated $4.15B in revenue during NA 2023, up 10.03% compared to the previous quarter, and up 113.12% compared to the same period a year ago.

Bausch + Lomb Revenue by Quarter

DateRevenueChange
2024-09-30--1.64%
2024-06-30-10.65%
2024-03-31--6.31%
2023-12-31-16.48%
2023-09-30--2.71%
2023-06-30-11.17%
2023-03-31--6.53%
2022-12-31-5.73%
2022-09-30-0.11%
2022-06-30-5.85%
2022-03-31--11.19%
2021-12-31-5.48%
2021-09-30-1.61%
2021-06-30-6.02%
2021-03-31--6.67%
2020-12-31-3.06%
2020-09-30-18.04%
2020-06-30--
2020-03-31--

Bausch + Lomb generated $1.20B in revenue during Q3 2024, up -1.64% compared to the previous quarter, and up 115.56% compared to the same period a year ago.

Bausch + Lomb Revenue Breakdown

Bausch + Lomb Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Device Products--
Over the Counter Products--
Pharmaceutical Products--
Branded and Other Generic Products--
Other Revenues--
Product--
Product and Service, Other--

Bausch + Lomb's latest annual revenue breakdown by segment (product or service), as of Dec 23: Device Products (39.80%), Over the Counter Products (38.86%), Pharmaceutical Products (14.91%), Branded and Other Generic Products (6.08%), and Other Revenues (0.36%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
Branded and Other Generic Products-----------
Device Products-----------
Other Revenues-----------
Over the Counter Products-----------
Pharmaceutical Products-----------
Product-----------
Product and Service, Other-----------

Bausch + Lomb's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Device Products (38.04%), Over the Counter Products (35.12%), Pharmaceutical Products (20.65%), Branded and Other Generic Products (5.85%), and Other Revenues (0.33%).

Bausch + Lomb Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22
JAPAN--
KOREA, REPUBLIC OF--
CANADA--
CHINA--
FRANCE--
GERMANY--
MEXICO--
Other Countries--
POLAND--
SPAIN--
United States and Puerto Rico--
ITALY--

Bausch + Lomb's latest annual revenue breakdown by geography, as of Dec 23: United States and Puerto Rico (49.35%), Other Countries (16.71%), CHINA (8.78%), FRANCE (5.36%), JAPAN (4.77%), GERMANY (3.75%), CANADA (2.81%), SPAIN (2.17%), ITALY (2.09%), MEXICO (1.74%), POLAND (1.30%), and KOREA, REPUBLIC OF (1.17%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22
MEXICO-----------
KOREA, REPUBLIC OF-----------
JAPAN-----------
FRANCE-----------
CANADA-----------
CHINA-----------
ITALY-----------
GERMANY-----------
United States and Puerto Rico-----------
SPAIN-----------
POLAND-----------
Other Countries-----------
AUSTRALIA-----------
SWEDEN-----------

Bausch + Lomb's latest quarterly revenue breakdown by geography, as of Sep 24: United States and Puerto Rico (53.80%), Other Countries (15.37%), CHINA (8.13%), FRANCE (4.59%), JAPAN (3.98%), GERMANY (3.36%), CANADA (2.92%), ITALY (1.94%), SPAIN (1.77%), MEXICO (1.59%), POLAND (1.50%), and KOREA, REPUBLIC OF (1.06%).

Bausch + Lomb Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BDXBecton, Dickinson and Company--
ALCAlcon--
RMDResMed--
BLCOBausch + Lomb--
HOLXHologic--
COOCooper Companies--
ATRAptarGroup--
TFXTeleflex--
WSTWest Pharmaceutical Services--
ICUIICU Medical--
HAEHaemonetics--
ATRCAtriCure--
ANGOAngioDynamics--
AKYAAkoya Biosciences--
ATRIAtrion--

BLCO Revenue FAQ

What is Bausch + Lomb’s yearly revenue?

Bausch + Lomb's yearly revenue for 2023 was $4.15B, representing an increase of 10.03% compared to 2022. The company's yearly revenue for 2022 was $3.77B, representing an increase of 0.08% compared to 2021. BLCO's yearly revenue for 2021 was $3.76B, representing an increase of 10.35% compared to 2020.

What is Bausch + Lomb’s quarterly revenue?

Bausch + Lomb's quarterly revenue for Q3 2024 was $1.2B, a -1.64% decrease from the previous quarter (Q2 2024), and a 18.77% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $1.22B, a 10.65% increase from the previous quarter (Q1 2024), and a 17.49% increase year-over-year (Q2 2023). BLCO's quarterly revenue for Q1 2024 was $1.1B, a -6.31% decrease from the previous quarter (Q4 2023), and a 18.05% increase year-over-year (Q1 2023).

What is Bausch + Lomb’s revenue growth rate?

Bausch + Lomb's revenue growth rate for the last 3 years (2021-2023) was 10.12%, and for the last 5 years (2019-2023) was 9.74%.

What are Bausch + Lomb’s revenue streams?

Bausch + Lomb's revenue streams in c 23 are Device Products, Over the Counter Products, Pharmaceutical Products, Branded and Other Generic Products, and Other Revenues. Device Products generated $1.65B in revenue, accounting 39.80% of the company's total revenue Over the Counter Products generated $1.61B in revenue, accounting 38.86% of the company's total revenue Pharmaceutical Products generated $618M in revenue, accounting 14.91% of the company's total revenue Branded and Other Generic Products generated $252M in revenue, accounting 6.08% of the company's total revenue Other Revenues generated $15M in revenue, accounting 0.36% of the company's total revenue

What is Bausch + Lomb’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Bausch + Lomb was Device Products. This segment made a revenue of $1.65B, representing 39.80% of the company's total revenue.